PMID- 2180683 OWN - NLM STAT- MEDLINE DCOM- 19900430 LR - 20131121 IS - 0013-7227 (Print) IS - 0013-7227 (Linking) VI - 126 IP - 4 DP - 1990 Apr TI - Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats. PG - 2145-52 AB - Interleukin-1 (IL-1), a polypeptide cytokine secreted by activated macrophages, has been postulated as a chemical messenger between the immune and endocrine systems. IL-1-immunopositive neurons and fibers have been visualized in the human and rat hypothalamus, and IL-1 receptors are present in the rat brain. We have examined the effects of human recombinant IL-1 (alpha- and beta-subtypes) on LH release in vivo and hypothalamic LHRH release in vitro. Ovariectomized rats were primed with estradiol benzoate, and progesterone was injected 48 h later to elicit a LH surge in the afternoon. IL-1 alpha and IL-1 beta were injected either intracerebroventricularly (icv) via a preimplanted cannula in the third ventricle of the brain or iv. Systemic injection of IL-1 alpha or IL-1 beta (58.8 pmol at 1300 and 1500 h) failed to influence the afternoon LH surge seen in saline-injected control rats. However, IL-1 beta (1.76 pmol) administered icv at 1300 and 1500 h or a single icv injection at 1300 h blocked the progesterone-induced LH surge. Similar icv injections of IL-1 alpha also significantly suppressed the afternoon LH surge compared to that in saline-injected control rats. However, IL-1 alpha was relatively less effective than the beta-subtype, since the LH surge was detected in some rats. To ascertain whether suppression of the LH surge was due to inhibition of LHRH release, the medial basal hypothalamus-preoptic area of estradiol benzoate-progesterone-treated ovariectomized rats was incubated with and without IL-1. Both IL-1 alpha and IL-1 beta, at concentrations of 0.1 nM and higher, significantly suppressed LHRH release in vitro from the medial basal hypothalamus-preoptic area. In contrast, IL-1 (10 nM) was completely ineffective in suppressing LHRH release from the microdissected median eminence. These results demonstrated an overall inhibitory effect of icv IL-1 on the LHRH-LH axis and suggest that suppression of the steroid-induced LH surge by IL-1 may primarily be due to inhibition of LHRH release at hypothalamic sites located within the blood-brain barrier. FAU - Kalra, P S AU - Kalra PS AD - Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville 32610. FAU - Sahu, A AU - Sahu A FAU - Kalra, S P AU - Kalra SP LA - eng GR - HD-11362/HD/NICHD NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Endocrinology JT - Endocrinology JID - 0375040 RN - 0 (Interleukin-1) RN - 33515-09-2 (Gonadotropin-Releasing Hormone) RN - 4G7DS2Q64Y (Progesterone) RN - 4TI98Z838E (Estradiol) RN - 9002-67-9 (Luteinizing Hormone) SB - IM MH - Animals MH - Estradiol/pharmacology MH - Female MH - Gonadotropin-Releasing Hormone/*metabolism MH - Hypothalamus/*metabolism MH - Injections, Intraventricular MH - Interleukin-1/*pharmacology MH - Luteinizing Hormone/*metabolism MH - Progesterone/*physiology MH - Rats MH - Rats, Inbred Strains EDAT- 1990/04/01 00:00 MHDA- 1990/04/01 00:01 CRDT- 1990/04/01 00:00 PHST- 1990/04/01 00:00 [pubmed] PHST- 1990/04/01 00:01 [medline] PHST- 1990/04/01 00:00 [entrez] AID - 10.1210/endo-126-4-2145 [doi] PST - ppublish SO - Endocrinology. 1990 Apr;126(4):2145-52. doi: 10.1210/endo-126-4-2145.